Measuring HIV-1 RNA and interferon-α in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex

A Krivine, G Force, J Servan, AE Cabée… - Journal of …, 1999 - Taylor & Francis
A Krivine, G Force, J Servan, AE Cabée, F Rozenberg, L Dighiero, F Marguet, P Lebon
Journal of neurovirology, 1999Taylor & Francis
The aim of this work was to study the role of HIV replication and the role of endogenous
secretion of interferon-α in the pathogenesis of AIDS Dementia Complex (ADC). To
accurately establish the diagnosis of ADC, 39 consecutive HIV-positive patients who
presented with immune and intellectual deficiency underwent an extensive neurological
evaluation. This included magnetic resonance imaging, neuropsychological testing and a
lumbar puncture. The levels of HIV-1 RNA were measured in the cerebrospinal fluid (CSF) …
The aim of this work was to study the role of HIV replication and the role of endogenous secretion of interferon-α in the pathogenesis of AIDS Dementia Complex (ADC). To accurately establish the diagnosis of ADC, 39 consecutive HIV-positive patients who presented with immune and intellectual deficiency underwent an extensive neurological evaluation. This included magnetic resonance imaging, neuropsychological testing and a lumbar puncture. The levels of HIV-1 RNA were measured in the cerebrospinal fluid (CSF) and blood by HIV Monitor (Roche Diagnostics) and those of interferon-α by an in-house biological assay. The diagnosis of ADC was established in 22 cases, which included nine out of the ten patients who had a high CSF viral load (above 4 log HIV-1 RNA copy per ml). Patients receiving highly active antiretroviral therapy had low viral loads in blood and CSF. In all 22 ADC patients, viral load in the CSF correlated with the staging of ADC (r = 0.46, P = 0.03), the CSF level of interferon-α (r = 0.42, P = 0.05) and with the bicaudate ratio (r = 0.43, P = 0.06), a measure of cerebral atrophy in the region of the caudate nucleus. No correlation was observed between CSF and plasma HIV-1 RNA. These results show that HIV may play a role in the neurological impairment of ADC patients possibly in part through the deleterious effect of interferon-α on the central nervous system and that highly active combination therapy should reduce or prevent these complications.
Taylor & Francis Online